Grant
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)
An NIH grant supporting early-career scientists transitioning to entrepreneurship via STTR Phase I and Fast-Track applications. In addition to R&D funding, it provides entrepreneurial training, mentoring, and career development.
See your fitKey facts
- Organiser
- National Institutes of Health
- Deadline
- January 5, 2027
- Cycles
- Forecasted Cycle · deadline January 5, 2027
- Opens
- November 5, 2026
- Amount
- Grant
- Open to
- United States
- Sectors
- Biotech, Healthtech
3 details are locked
See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.
See your fitKey questions about Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)
Who can apply to Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)?
Eligible locations: United States. The company must be incorporated in United States. Only startups in these sectors qualify: Biotech and Healthtech. Other requirements: PI must never have been an independent PD/PI on NIH/CDC/peer-reviewed research grant; PI must be a U.S. Citizen or Lawful Permanent Resident; Key personnel must include a mentor with measurable effort committed.
When is the Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) deadline?
The Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) deadline is January 5, 2027. Upcoming cycles: Forecasted Cycle · deadline January 5, 2027. Applications opened on November 5, 2026.
Other programs in this category
Programs like this in the United States
Verified on November 17, 2026 against the official page.